Correlation Between Cannabics Pharmaceuticals and Scopus Biopharma

Can any of the company-specific risk be diversified away by investing in both Cannabics Pharmaceuticals and Scopus Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cannabics Pharmaceuticals and Scopus Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cannabics Pharmaceuticals and Scopus Biopharma, you can compare the effects of market volatilities on Cannabics Pharmaceuticals and Scopus Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cannabics Pharmaceuticals with a short position of Scopus Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cannabics Pharmaceuticals and Scopus Biopharma.

Diversification Opportunities for Cannabics Pharmaceuticals and Scopus Biopharma

-0.17

Correlation Coefficient

Cannabics Pharmaceuticals  Scopus Biopharma

Good diversification

The 3 months correlation between Cannabics and Scopus is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding Cannabics Pharmaceuticals and Scopus Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Scopus Biopharma and Cannabics Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cannabics Pharmaceuticals are associated (or correlated) with Scopus Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Scopus Biopharma has no effect on the direction of Cannabics Pharmaceuticals i.e., Cannabics Pharmaceuticals and Scopus Biopharma go up and down completely randomly.

Pair Corralation between Cannabics Pharmaceuticals and Scopus Biopharma

If you would invest  1.17  in Cannabics Pharmaceuticals on October 12, 2024 and sell it today you would lose (0.17) from holding Cannabics Pharmaceuticals or give up 14.53% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	0.53%
Values	Daily Returns

Cannabics Pharmaceuticals  vs.  Scopus Biopharma

Cannabics Pharmaceuticals

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Cannabics Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent fundamental drivers, Cannabics Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Scopus Biopharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Scopus Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Scopus Biopharma is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Cannabics Pharmaceuticals and Scopus Biopharma

The main advantage of trading using opposite Cannabics Pharmaceuticals and Scopus Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cannabics Pharmaceuticals position performs unexpectedly, Scopus Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Scopus Biopharma will offset losses from the drop in Scopus Biopharma's long position.

The idea behind Cannabics Pharmaceuticals and Scopus Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.